AstraZeneca (AZN)
(Real Time Quote from BATS)
$78.74 USD
+1.63 (2.11%)
Updated May 21, 2024 01:14 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Brokerage Reports
AstraZeneca PLC [AZN]
Reports for Purchase
Showing records 61 - 80 ( 256 total )
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Durvalumab COAST Update Makes a Splash at ESMO
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Key Takeaways From COVID-19 Vaccines and Antivirals Panels at Life Sciences Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 26
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 19
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D